Retinal pigment epithelium tears: classification, pathogenesis, predictors, and management

MG Ersoz, M Karacorlu, S Arf, IS Muslubas… - Survey of …, 2017 - Elsevier
Various eye conditions cause tears in the retinal pigment epithelium (RPE). The most
common cause of a RPE tear is vascularized retinal pigment epithelial detachment (PED) in …

Retinal pigment epithelium tears: risk factors, mechanism and therapeutic monitoring

CR Clemens, N Eter - Ophthalmologica, 2016 - karger.com
Tears of the retinal pigment epithelium (RPE) are most commonly associated with
vascularised RPE detachment due to age-related macular degeneration (AMD), and they …

Pigment epithelial tears associated with anti-VEGF therapy: incidence, long-term visual outcome, and relationship with pigment epithelial detachment in age-related …

S Doguizi, S Ozdek - Retina, 2014 - journals.lww.com
Purpose: To evaluate the prevalence of retinal pigment epithelium (RPE) tears associated
with anti-VEGF therapy and its relation with retinal pigment epithelial detachment (PED) …

[HTML][HTML] Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and treatment (an American Ophthalmological …

D Sarraf, A Joseph, E Rahimy - Transactions of the American …, 2014 - ncbi.nlm.nih.gov
Purpose: To describe the risk factors, pathogenesis, and prognosis of retinal pigment
epithelial (RPE) tears and to demonstrate our hypothesis that continued anti–vascular …

[HTML][HTML] Intravitreal injection of anti-vascular endothelial growth factor agents for ocular vascular diseases: clinical practice guideline

H Nikkhah, S Karimi, H Ahmadieh… - Journal of ophthalmic …, 2018 - ncbi.nlm.nih.gov
Purpose: To provide the clinical recommendations for the administration of intravitreal anti-
vascular endothelial growth factor (VEGF) drugs especially bavacizumab for ocular vascular …

Ocular and systemic safety of bevacizumab and ranibizumab in patients with neovascular age-related macular degeneration

D Johnson, S Sharma - Current Opinion in Ophthalmology, 2013 - journals.lww.com
Ocular and systemic safety of bevacizumab and ranibizumab in... : Current Opinion in
Ophthalmology Ocular and systemic safety of bevacizumab and ranibizumab in patients with …

Retinal pigment epithelial tear and anti-vascular endothelial growth factor therapy in exudative age-related macular degeneration: clinical course and long-term …

B Heimes, ML Farecki Jr, S Bartels, A Barrelmann… - Retina, 2016 - journals.lww.com
Background: To document the long-term outcome in cases of retinal pigment epithelial
(RPE) tears after treatment of vascularized pigment epithelial detachments with anti …

[HTML][HTML] Optical coherence tomographic and visual results at six months after transitioning to aflibercept for patients on prior ranibizumab or bevacizumab treatment for …

CK Chan, A Jain, S Sadda… - Transactions of the …, 2014 - ncbi.nlm.nih.gov
Purpose: To study optical coherence tomographic (OCT) results and vision at 6 months after
transition (post-Tx) from intravitreal bevacizumab and/or ranibizumab to aflibercept for …

Incidence and long-term visual acuity outcomes of retinal pigment epithelium tears after intravitreal anti–vascular endothelial growth factor treatment of neovascular …

C Vazquez-Alfageme, L Nicholson, RD Hamilton… - Retina, 2019 - journals.lww.com
Purpose: To report the incidence of retinal pigment epithelium tears in eyes treated with
aflibercept for neovascular age-related macular degeneration and compare it with …

RETINAL PIGMENT EPITHELIUM–CHOROID GRAFT WITH A PERIPHERAL RETINOTOMY FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Long …

SHM van Romunde, A Polito, AP Deiro, M Guerriero… - Retina, 2019 - journals.lww.com
Purpose: To investigate the long-term outcome of autologous retinal pigment epithelium–
choroid transplantation with a peripheral retinotomy for exudative age-related macular …